AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 159 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 9.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $59,000 | +103.4% | 3,944 | +3.7% | 0.00% | – |
| Q2 2022 | $29,000 | -14.7% | 3,805 | +3.3% | 0.00% | – |
| Q1 2022 | $34,000 | +277.8% | 3,685 | +174.4% | 0.00% | – |
| Q4 2021 | $9,000 | -64.0% | 1,343 | -37.5% | 0.00% | – |
| Q3 2021 | $25,000 | -21.9% | 2,150 | +8.3% | 0.00% | – |
| Q2 2021 | $32,000 | -8.6% | 1,986 | +2.6% | 0.00% | – |
| Q1 2021 | $35,000 | +16.7% | 1,935 | -11.4% | 0.00% | – |
| Q4 2020 | $30,000 | +87.5% | 2,184 | +66.7% | 0.00% | – |
| Q3 2020 | $16,000 | +433.3% | 1,310 | +661.6% | 0.00% | – |
| Q2 2020 | $3,000 | +50.0% | 172 | +45.8% | 0.00% | – |
| Q1 2020 | $2,000 | -60.0% | 118 | -46.4% | 0.00% | – |
| Q4 2019 | $5,000 | 0.0% | 220 | -21.7% | 0.00% | – |
| Q3 2019 | $5,000 | 0.0% | 281 | +79.0% | 0.00% | – |
| Q2 2019 | $5,000 | -81.5% | 157 | -72.5% | 0.00% | – |
| Q1 2019 | $27,000 | +350.0% | 570 | +249.7% | 0.00% | – |
| Q4 2018 | $6,000 | -91.0% | 163 | -85.2% | 0.00% | – |
| Q3 2018 | $67,000 | +26.4% | 1,100 | +40.1% | 0.00% | – |
| Q2 2018 | $53,000 | +6.0% | 785 | -15.8% | 0.00% | – |
| Q1 2018 | $50,000 | +8.7% | 932 | +22.0% | 0.00% | – |
| Q4 2017 | $46,000 | +91.7% | 764 | +55.6% | 0.00% | – |
| Q3 2017 | $24,000 | -82.7% | 491 | -88.9% | 0.00% | -100.0% |
| Q1 2015 | $139,000 | +0.7% | 4,430 | -6.5% | 0.00% | 0.0% |
| Q4 2014 | $138,000 | – | 4,740 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |